March 19, 2024
AstraZeneca signs agreement to acquire Fusion Pharmaceuticals
AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals, a move set to bolster its oncology portfolio with innovative radioconjugates (RCs).